Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation

On the relationship of YAP and FAK in hMSCs and osteosarcoma cells: Discrimination of FAK modulation by nuclear YAP depletion or YAP silencing

(2019) Ayman Husari et al.   CELLULAR SIGNALLING

Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice

(2019) Swati Prakash et al.   BIOCHIMIE

Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma

(2018) Ahmed M. Kabel et al.   BIOMEDICINE & PHARMACOTHERAPY

The Hippo pathway as a drug target in gastric cancer

(2018) Yiting Qiao et al.   CANCER LETTERS

YAP/TAZ upstream signals and downstream responses

(2018) Antonio Totaro et al.   NATURE CELL BIOLOGY

Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice

(2018) Wenbin Zheng et al.   International Journal of Endocrinology

Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

(2018) Ádám Nagy et al.   Scientific Reports

YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma

(2018) Min Hwan Kim et al.   Cancer Immunology Research

Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis

(2017) Maria Teresa Salcedo Allende et al.   PANCREAS

MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients

(2017) Yishui Lian et al.   PATHOLOGY RESEARCH AND PRACTICE

YAP/TAZ at the Roots of Cancer

(2016) Francesca Zanconato et al.   CANCER CELL

Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer

(2016) Chen Xie et al.   CELLULAR ONCOLOGY

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

(2016) Zhengdong Jiang et al.   Nutrients

Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

(2015) Jung-Soon Mo et al.   NATURE CELL BIOLOGY

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

(2015) Rosa Barreira da Silva et al.   NATURE IMMUNOLOGY

Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis

(2014) A. N. Lau et al.   EMBO JOURNAL

Diabetes mellitus increases the risk of early gastric cancer development

(2014) Akira Sekikawa et al.   EUROPEAN JOURNAL OF CANCER

Diabetes and gastric cancer: The potential links

(2014) Chin-Hsiao Tseng   WORLD JOURNAL OF GASTROENTEROLOGY

Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

(2014) Swee Seong Wong et al.   Nature Communications

Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein

(2014) Michael DeRan et al.   Cell Reports

Novel immunodominant epitopes derived from MAGE-A3 and its significance in serological diagnosis of gastric cancer

(2013) Xian Shen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

(2011) Maria M. Mihaylova et al.   NATURE CELL BIOLOGY

The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation

(2010) I. Lian et al.   GENES & DEVELOPMENT